공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

세계의 체외(IV) 폐 모델 시장

In Vitro Lung Model

리서치사 Global Industry Analysts, Inc.
발행일 2021년 04월 상품 코드 997483
페이지 정보 영문 108 Pages
가격
US $ 4,950 ₩ 5,625,000 PDF (Single User License) help
DRM(디지털 저작권 관리 시스템)이 장착된 PDF 파일로 1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste 가 되지 않으며, 인쇄는 1회에 한해 가능합니다. 인쇄물 이용은 PDF 라이선스 소유자로 한정됩니다.
US $ 14,850 ₩ 16,875,000 PDF (Global License to Company and its Fully-owned Subsidiaries) help
동일 기업 및 100% 자회사의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수 제한은 없습니다. PDF 파일은 Copy & Paste 가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.

주의 : 본 보고서는 DRM(디지털 저작권 관리 시스템)이 장착된 PDF 파일로, 라이선스에 따라 자료 이용 및 인쇄 등에 제약이 있을 수 있습니다. 자세한 내용은 라이선스 설명문( )을 참고하여 주시기 바랍니다.



세계의 체외(IV) 폐 모델 시장 In Vitro Lung Model
발행일 : 2021년 04월 페이지 정보 : 영문 108 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계 체외(IV) 폐 모델 시장 규모는 분석기간(2020-2027년)에 17.1%의 연평균 복합 성장률(CAGR)로 성장할 전망이며, 2020년 2억 2,100만 달러에서 2027년에는 6억 6,630만 달러에 달할 것으로 예측됩니다.

본 보고서에서 분석한 부문 중 하나인 2D는 분석기간 중 16.4%의 CAGR을 나타내고, 4억 1,170만 달러에 달할 전망입니다.

세계의 체외 폐 모델(In Vitro Lung Model) 시장에 대해 조사했으며, 시장 점유율, COVID-19의 영향, 동향 및 성장요인, 지역별 시장 분석, 경쟁 구도, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.

조사 대상 기업 예

  • CN Bio Innovations Ltd.
  • Emulate, Inc.
  • Epithelix Sarl
  • InSphero AG
  • Lonza Group AG
  • MatTek Corporation
  • Mimetas
  • TissUse GmbH

목차

I. 조사 방법

II. 개요

  • 시장 개요
    • 인플루언서 시장 인사이트
    • 코로나19(COVID-19)의 영향과 다가오는 세계 경기침체
  • 주요 기업
  • 동향 및 성장요인
  • 세계 시장 전망

III. 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 기타 유럽
  • 아시아태평양
  • 기타 지역

IV. 경쟁

  • 기업 개요 : 42개사
LSH 21.04.08

Abstract:

Global In Vitro Lung Model Market to Reach $666.3 Million by 2027

Amid the COVID-19 crisis, the global market for In Vitro Lung Model estimated at US$221 Million in the year 2020, is projected to reach a revised size of US$666.3 Million by 2027, growing at aCAGR of 17.1% over the period 2020-2027. 2D, one of the segments analyzed in the report, is projected to record 16.4% CAGR and reach US$411.7 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the 3D segment is readjusted to a revised 18.3% CAGR for the next 7-year period.

The U.S. Market is Estimated at $65.4 Million, While China is Forecast to Grow at 16.5% CAGR

The In Vitro Lung Model market in the U.S. is estimated at US$65.4 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$115.5 Million by the year 2027 trailing a CAGR of 16.5% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 15.1% and 14.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 12.6% CAGR.

Select Competitors (Total 42 Featured) -

  • CN Bio Innovations Ltd.
  • Emulate, Inc.
  • Epithelix Sarl
  • InSphero AG
  • Lonza Group AG
  • MatTek Corporation
  • Mimetas
  • TissUse GmbH

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for In Vitro Lung Model by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
    • TABLE 2: World 7-Year Perspective for In Vitro Lung Model by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2020 & 2027
    • TABLE 3: World Current & Future Analysis for 2D by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
    • TABLE 4: World 7-Year Perspective for 2D by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
    • TABLE 5: World Current & Future Analysis for 3D by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
    • TABLE 6: World 7-Year Perspective for 3D by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027

III. MARKET ANALYSIS

  • UNITED STATES
    • TABLE 7: USA Current & Future Analysis for In Vitro Lung Model by Type - 2D and 3D - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
    • TABLE 8: USA 7-Year Perspective for In Vitro Lung Model by Type - Percentage Breakdown of Value Sales for 2D and 3D for the Years 2020 & 2027
  • CANADA
    • TABLE 9: Canada Current & Future Analysis for In Vitro Lung Model by Type - 2D and 3D - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
    • TABLE 10: Canada 7-Year Perspective for In Vitro Lung Model by Type - Percentage Breakdown of Value Sales for 2D and 3D for the Years 2020 & 2027
  • JAPAN
    • TABLE 11: Japan Current & Future Analysis for In Vitro Lung Model by Type - 2D and 3D - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
    • TABLE 12: Japan 7-Year Perspective for In Vitro Lung Model by Type - Percentage Breakdown of Value Sales for 2D and 3D for the Years 2020 & 2027
  • CHINA
    • TABLE 13: China Current & Future Analysis for In Vitro Lung Model by Type - 2D and 3D - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
    • TABLE 14: China 7-Year Perspective for In Vitro Lung Model by Type - Percentage Breakdown of Value Sales for 2D and 3D for the Years 2020 & 2027
  • EUROPE
    • TABLE 15: Europe Current & Future Analysis for In Vitro Lung Model by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
    • TABLE 16: Europe 7-Year Perspective for In Vitro Lung Model by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2020 & 2027
    • TABLE 17: Europe Current & Future Analysis for In Vitro Lung Model by Type - 2D and 3D - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
    • TABLE 18: Europe 7-Year Perspective for In Vitro Lung Model by Type - Percentage Breakdown of Value Sales for 2D and 3D for the Years 2020 & 2027
  • FRANCE
    • TABLE 19: France Current & Future Analysis for In Vitro Lung Model by Type - 2D and 3D - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
    • TABLE 20: France 7-Year Perspective for In Vitro Lung Model by Type - Percentage Breakdown of Value Sales for 2D and 3D for the Years 2020 & 2027
  • GERMANY
    • TABLE 21: Germany Current & Future Analysis for In Vitro Lung Model by Type - 2D and 3D - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
    • TABLE 22: Germany 7-Year Perspective for In Vitro Lung Model by Type - Percentage Breakdown of Value Sales for 2D and 3D for the Years 2020 & 2027
  • ITALY
    • TABLE 23: Italy Current & Future Analysis for In Vitro Lung Model by Type - 2D and 3D - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
    • TABLE 24: Italy 7-Year Perspective for In Vitro Lung Model by Type - Percentage Breakdown of Value Sales for 2D and 3D for the Years 2020 & 2027
  • UNITED KINGDOM
    • TABLE 25: UK Current & Future Analysis for In Vitro Lung Model by Type - 2D and 3D - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
    • TABLE 26: UK 7-Year Perspective for In Vitro Lung Model by Type - Percentage Breakdown of Value Sales for 2D and 3D for the Years 2020 & 2027
  • REST OF EUROPE
    • TABLE 27: Rest of Europe Current & Future Analysis for In Vitro Lung Model by Type - 2D and 3D - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
    • TABLE 28: Rest of Europe 7-Year Perspective for In Vitro Lung Model by Type - Percentage Breakdown of Value Sales for 2D and 3D for the Years 2020 & 2027
  • ASIA-PACIFIC
    • TABLE 29: Asia-Pacific Current & Future Analysis for In Vitro Lung Model by Type - 2D and 3D - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
    • TABLE 30: Asia-Pacific 7-Year Perspective for In Vitro Lung Model by Type - Percentage Breakdown of Value Sales for 2D and 3D for the Years 2020 & 2027
  • REST OF WORLD
    • TABLE 31: Rest of World Current & Future Analysis for In Vitro Lung Model by Type - 2D and 3D - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
    • TABLE 32: Rest of World 7-Year Perspective for In Vitro Lung Model by Type - Percentage Breakdown of Value Sales for 2D and 3D for the Years 2020 & 2027

IV. COMPETITION

  • Total Companies Profiled: 42
Back to Top
전화 문의
F A Q